These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10892324)

  • 1. NSAIDs: a Faustian bargain.
    Peloso PM
    Am J Nurs; 2000 Jun; 100(6):34-9; quiz 43. PubMed ID: 10892324
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is misoprostol effective in NSAID-induced gastrointestinal complications?].
    Stucki G; Sangha O; Michel BA
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1573-8. PubMed ID: 8927962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs.
    Maetzel A; Ferraz MB; Bombardier C
    Arthritis Rheum; 1998 Jan; 41(1):16-25. PubMed ID: 9433865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol and gastrointestinal complications in patients taking nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
    Grossman CM
    Ann Intern Med; 1996 May; 124(10):926-7. PubMed ID: 8610928
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal events related to the use of non-steroidal anti-inflammatory drugs: some clinical and economic aspects.
    Eliakim R; Rachmilewitz D
    Isr J Med Sci; 1997 Oct; 33(10):696-9. PubMed ID: 9397147
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitigating GI risks associated with the use of NSAIDs.
    Momeni M; Katz JD
    Pain Med; 2013 Dec; 14 Suppl 1():S18-22. PubMed ID: 24373106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric mucosal injury induced by nonsteroidal anti-inflammatory drugs.
    Holt S; Saleeby G
    South Med J; 1991 Mar; 84(3):355-60. PubMed ID: 1900375
    [No Abstract]   [Full Text] [Related]  

  • 8. Reducing NSAID-induced gastrointestinal complications.
    Drug Ther Bull; 2011 Feb; 49(2):18-21; quiz i-ii. PubMed ID: 21304164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: are older strategies more cost-effective in the general population?
    Elliott RA; Hooper L; Payne K; Brown TJ; Roberts C; Symmons D
    Rheumatology (Oxford); 2006 May; 45(5):606-13. PubMed ID: 16368733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of misoprostol in the elderly: is the expense justified?
    Stucki G; Johannesson M; Liang MH
    Drugs Aging; 1996 Feb; 8(2):84-8. PubMed ID: 8845589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract.
    Sung J; Russell RI; Nyeomans ; Chan FK; Chen S; Fock K; Goh KL; Kullavanijaya P; Kimura K; Lau C; Louw J; Sollano J; Triadiafalopulos G; Xiao S; Brooks P
    J Gastroenterol Hepatol; 2000 Oct; 15 Suppl():G58-68. PubMed ID: 11100995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Questionnaire on NSAID gastropathy among Dutch rheumatologists.
    Steen KS; Lems WF; Dijkmans BA
    Clin Rheumatol; 2000; 19(3):193-4. PubMed ID: 10870652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.
    Wolfe MM; Lichtenstein DR; Singh G
    N Engl J Med; 1999 Jun; 340(24):1888-99. PubMed ID: 10369853
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerability of pantoprazole compared with misoprostol for the prevention of NSAID-related gastrointestinal lesions and symptoms in rheumatic patients.
    Stupnicki T; Dietrich K; González-Carro P; Straszak A; Terjung A; Thomas KB; Lühmann R; Fischer R
    Digestion; 2003; 68(4):198-208. PubMed ID: 14707396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial.
    Simon LS; Hatoum HT; Bittman RM; Archambault WT; Polisson RP
    Fam Med; 1996 Mar; 28(3):204-10. PubMed ID: 8900554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM; Saggioro A
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is NSAIDs-related gastrointestinal damage preventable?
    Gargallo CJ; Lanas A
    J Dig Dis; 2013 Feb; 14(2):55-61. PubMed ID: 23216831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.
    Yuan JQ; Tsoi KK; Yang M; Wang JY; Threapleton DE; Yang ZY; Zou B; Mao C; Tang JL; Chan FK
    Aliment Pharmacol Ther; 2016 Jun; 43(12):1262-75. PubMed ID: 27121479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Misoprostol].
    Sáinz Samitier R
    Gastroenterol Hepatol; 1995 Mar; 18(3):153-61. PubMed ID: 7621293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.